MetaCap

Biofrontera Insider Trades

NASDAQ: BFRIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.53-0.04 (-7.02%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Biofrontera insider activity

Over the last 12 months, Biofrontera insiders reported 4 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Luebbert Hermann (CEO & Chairman) reporting a transaction in 62,500 shares on Jul 28, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BFRI's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

BFRI insider transactions

Biofrontera insider transactions
DateInsiderTypeSharesValueFiling
Jul 28, 2026Leffler Eugene FrederickChief Financial OfficerOption exercise31,250—Form 4
Jul 28, 2026Luebbert HermannCEO & ChairmanOption exercise62,500—Form 4
Mar 5, 2026Luebbert HermannCEO & ChairmanOption exercise137,500—Form 4
Mar 5, 2026Leffler Eugene FrederickChief Financial OfficerOption exercise87,500—Form 4
Sep 10, 2025Leffler Eugene FrederickChief Financial OfficerOption exercise87,500—Form 4
Sep 10, 2025Luebbert HermannCEO & ChairmanOption exercise137,500—Form 4
May 18, 2024Luebbert HermannCEO & Exec. ChairmanOption exercise4,771—Form 4
May 18, 2023Luebbert HermannExecutive ChairmanOption exercise95,420—Form 4
May 18, 2023Monaco Erica L.Chief Executive OfficerOption exercise76,336—Form 4
Aug 22, 2022Luebbert HermannExecutive ChairmanOption exercise113,379—Form 4
Jul 1, 2022Monaco Erica L.Chief Executive OfficerOption exercise56,689—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related